Kestra Advisory Services’s AbbVie ABBV Stock Holding History

Kestra Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107M	Sell	426,678 -4,903	-1%	-$1.05M	0.35%	48
2026 Q1	$93.9M	Buy	431,581 +20,714	+5%	+$4.59M	0.36%	46
2025 Q4	$93.9M	Buy	410,867 +19,253	+5%	+$4.39M	0.39%	43
2025 Q3	$90.7M	Buy	391,614 +40,288	+11%	+$8.2M	0.41%	36
2025 Q2	$65.2M	Buy	351,326 +12,671	+4%	+$2.35M	0.32%	50
2025 Q1	$71M	Sell	338,655 -8,507	-2%	-$1.65M	0.34%	33
2024 Q4	$61.7M	Sell	347,162 -7,607	-2%	-$1.4M	0.34%	53
2024 Q3	$70.1M	Sell	354,769 -17,681	-5%	-$3.3M	0.39%	39
2024 Q2	$63.9M	Buy	372,450 +66,345	+22%	+$11M	0.36%	45
2024 Q1	$55.7M	Buy	306,105 +16,994	+6%	+$2.93M	0.37%	39
2023 Q4	$44.8M	Buy	289,111 +5,962	+2%	+$869K	0.36%	45
2023 Q3	$42.2M	Sell	283,149 -53,877	-16%	-$7.91M	0.42%	37
2023 Q2	$45.4M	Buy	337,026 +41,499	+14%	+$6.09M	0.45%	31
2023 Q1	$47.1M	Sell	295,527 -60,875	-17%	-$9.31M	0.51%	28
2022 Q4	$57.6M	Sell	356,402 -1,563	-0.4%	-$240K	0.51%	28
2022 Q3	$48M	Buy	357,965 +69,687	+24%	+$10M	0.51%	26
2022 Q2	$44.2M	Buy	288,278 +15,852	+6%	+$2.42M	0.45%	33
2022 Q1	$44.2M	Sell	272,426 -56,292	-17%	-$8.18M	0.46%	33
2021 Q4	$44.5M	Sell	328,718 -6,828	-2%	-$807K	0.45%	34
2021 Q3	$36.2M	Buy	335,546 +24,493	+8%	+$2.8M	0.36%	51
2021 Q2	$35M	Buy	311,053 +5,411	+2%	+$609K	0.4%	43
2021 Q1	$33.1M	Buy	305,642 +7,785	+3%	+$833K	0.42%	40
2020 Q4	$31.4M	Buy	297,857 +65,546	+28%	+$6.3M	0.36%	52
2020 Q3	$20.4M	Buy	+232,311	New	+$21.9M	0.38%	49

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kestra Advisory Services's ABBV Position: Q2 2026 in Review

Kestra Advisory Services reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $1.05M and leaving 426,678 shares worth $107M. The position accounts for 0.35% of the portfolio, ranked #48.

Kestra Advisory Services first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kestra Advisory Services held 426,678 shares of AbbVie worth $107M as of Q2 2026.
Kestra Advisory Services sold 4,903 AbbVie shares in Q2 2026, an estimated $1.05M.
AbbVie made up 0.35% of Kestra Advisory Services's portfolio in Q2 2026, its #48 holding.
Kestra Advisory Services first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.